Deirdre Zander-Fox1,2,3, Michelle Lane4,5,6, Hamish Hamilton4,5, Kelton Tremellen4,7. 1. Repromed, 180 Fullarton Road, Dulwich, 5065, South Australia. dzander@repromed.com.au. 2. MonashIVF Group, 21-31 Goodwood Street, Richmond, Victoria, 3121, Australia. dzander@repromed.com.au. 3. Department of Obstetrics and Gynaecology, Medical School North, University of Adelaide, Frome Rd, Adelaide, 5000, Australia. dzander@repromed.com.au. 4. Repromed, 180 Fullarton Road, Dulwich, 5065, South Australia. 5. MonashIVF Group, 21-31 Goodwood Street, Richmond, Victoria, 3121, Australia. 6. Department of Obstetrics and Gynaecology, Medical School North, University of Adelaide, Frome Rd, Adelaide, 5000, Australia. 7. Department of Obstetrics Gynaecology and Reproductive Medicine, Flinders Medical Centre, Flinders University, Flinders Drive, Bedford Park, 5042, South Australia.
Abstract
PURPOSE: Mild controlled ovarian hyperstimulation (COH), combined with oocyte retrieval (OR) under local anaesthesia (LA), may provide low-impact IVF. Since a single injection of corifollitrophin alfa (CFA) provides 7 days of COH, we hypothesised that clomiphene-citrate (CC) followed by CFA may provide adequate COH response from one single FSH injection. Therefore, the aim was to assess IVF outcomes after a novel clomiphene citrate/CFA (CC/CFA) protocol, compared to women undergoing standard rFSH COH protocols (good prognosis comparative cohort:GPCC) in a 1:2 matched design. MATERIALS AND METHODS: In this pilot study of 25 patients (ANZCTR id:ACTRN12612000740897, MINIVA:Minimal_Stimulation_in_IVF), we examined the effectiveness of oral clomiphene (100 mg-days 2-6) followed by CFA in a GnRH antagonist protocol producing a single injection COH stimulation regime. All OR were conducted under LA pre-ovarian block. Cycle outcomes were compared to a matched good prognosis comparative cohort (GPCC) undergoing standard rFSH COH. RESULTS: Mild stimulation was achieved with less oocytes being collected compared to the GPCC (6.4 ± 0.7 vs. 10.7 ± 0.9, p < 0.001), resulting in a reduced number of good quality embryos available for transfer/cryopreservation (3.7 ± 0.6 vs. 5.7 ± 0.5, p = 0.01). While embryo quality was similar between the two groups, endometrial thickness was significantly lower in the group receiving CC/CFA. Pregnancy rates were significantly lower in the CC/CFA cohort compared to GPCC (31.8 vs. 57.1%, p = 0.04) and 44% of CC/CFA participants required supplemental rFSH in order to achieve the hCG trigger criteria. CONCLUSION: Sequential clomiphene CFA protocol does not appear to be an optimal regime for low impact IVF treatment as it does not provide adequate COH from a single CFA injection and results in lower fresh embryo transfer pregnancy rates and fewer embryos for cryopreservation.
PURPOSE: Mild controlled ovarian hyperstimulation (COH), combined with oocyte retrieval (OR) under local anaesthesia (LA), may provide low-impact IVF. Since a single injection of corifollitrophin alfa (CFA) provides 7 days of COH, we hypothesised that clomiphene-citrate (CC) followed by CFA may provide adequate COH response from one single FSH injection. Therefore, the aim was to assess IVF outcomes after a novel clomiphene citrate/CFA (CC/CFA) protocol, compared to women undergoing standard rFSH COH protocols (good prognosis comparative cohort:GPCC) in a 1:2 matched design. MATERIALS AND METHODS: In this pilot study of 25 patients (ANZCTR id:ACTRN12612000740897, MINIVA:Minimal_Stimulation_in_IVF), we examined the effectiveness of oral clomiphene (100 mg-days 2-6) followed by CFA in a GnRH antagonist protocol producing a single injection COH stimulation regime. All OR were conducted under LA pre-ovarian block. Cycle outcomes were compared to a matched good prognosis comparative cohort (GPCC) undergoing standard rFSH COH. RESULTS: Mild stimulation was achieved with less oocytes being collected compared to the GPCC (6.4 ± 0.7 vs. 10.7 ± 0.9, p < 0.001), resulting in a reduced number of good quality embryos available for transfer/cryopreservation (3.7 ± 0.6 vs. 5.7 ± 0.5, p = 0.01). While embryo quality was similar between the two groups, endometrial thickness was significantly lower in the group receiving CC/CFA. Pregnancy rates were significantly lower in the CC/CFA cohort compared to GPCC (31.8 vs. 57.1%, p = 0.04) and 44% of CC/CFAparticipants required supplemental rFSH in order to achieve the hCG trigger criteria. CONCLUSION: Sequential clomipheneCFA protocol does not appear to be an optimal regime for low impact IVF treatment as it does not provide adequate COH from a single CFA injection and results in lower fresh embryo transfer pregnancy rates and fewer embryos for cryopreservation.
Authors: Michelle van der Linden; Karen Buckingham; Cindy Farquhar; Jan A M Kremer; Mostafa Metwally Journal: Cochrane Database Syst Rev Date: 2015-07-07
Authors: Anna Cerne; Christina Bergh; Kia Borg; Ingvar Ek; Ann-Louise Gejervall; Torbjörn Hillensjö; Jan I Olofsson; Elisabet Stener-Victorin; Margareta Wood; Göran Westlander Journal: Hum Reprod Date: 2006-07-13 Impact factor: 6.918
Authors: Stamatina Iliodromiti; Christophe Blockeel; Kelton P Tremellen; Richard Fleming; Herman Tournaye; Peter Humaidan; Scott M Nelson Journal: Hum Reprod Date: 2013-07-19 Impact factor: 6.918
Authors: Adam H Balen; Lara C Morley; Marie Misso; Stephen Franks; Richard S Legro; Chandrika N Wijeyaratne; Elisabet Stener-Victorin; Bart C J M Fauser; Robert J Norman; Helena Teede Journal: Hum Reprod Update Date: 2016-08-10 Impact factor: 15.610
Authors: P Devroey; R Boostanfar; N P Koper; B M J L Mannaerts; P C Ijzerman-Boon; B C J M Fauser Journal: Hum Reprod Date: 2009-08-14 Impact factor: 6.918
Authors: Anderson Sanches de Melo; Camilla Teles Vidal de Paula; Thiago Lopes Dos Santos; Victor Antonio Costa Faria; Marcelo Augusto Feres Rufato; Rebecca Pontelo Barboza; Jorge Barreto Journal: JBRA Assist Reprod Date: 2022-04-17